Symbol Name ID |
Ifngr1
interferon gamma receptor 1 MGI:107655 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Increased circulating IgG level |
Increased circulating IgM level |
Leukocytosis |
Histiocytosis |
Enlarged mesenteric lymph node |
Lymphadenopathy |
Generalized lymphadenopathy |
Splenomegaly |
Hepatosplenomegaly |
Increased inflammatory response |
Osteomyelitis |
Salmonella osteomyelitis |
Pneumonia |
Rheumatoid factor positive |
Immunodeficiency |
Asthma |
Recurrent mycobacterial infections |
Recurrent mycobacterium avium complex infections |
Disease(s) Associated with IFNGR1 | ||||||||||||||||||
asthma | ||||||||||||||||||
immunodeficiency 27A | ||||||||||||||||||
immunodeficiency 27B |
Mouse Phenotypes | immune system phenotype |
arteritis |
aortitis |
abnormal osteoclast differentiation |
increased splenocyte proliferation |
abnormal uterine NK cell morphology |
increased uterine NK cell number |
abnormal lymphopoiesis |
increased B cell number |
decreased CD4-positive, alpha-beta T cell number |
decreased CD8-positive, alpha-beta T cell number |
decreased lymphocyte cell number |
decreased macrophage cell number |
spleen hypoplasia |
abnormal immunoglobulin level |
decreased IgG2a level |
decreased IgG3 level |
abnormal uterine NK cell physiology |
abnormal cytotoxic T cell physiology |
abnormal circulating chemokine level |
decreased circulating interferon-gamma level |
increased circulating interferon-gamma level |
increased circulating interleukin-1 beta level |
decreased circulating interleukin-12 level |
increased circulating interleukin-6 level |
decreased circulating tumor necrosis factor level |
abnormal chemokine level |
decreased interferon-gamma secretion |
increased interferon-gamma secretion |
decreased interleukin-12b secretion |
increased interleukin-6 secretion |
decreased tumor necrosis factor secretion |
increased tumor necrosis factor secretion |
decreased susceptibility to experimental autoimmune myasthenia gravis |
increased susceptibility to experimental autoimmune encephalomyelitis |
increased susceptibility to experimental autoimmune uveoretinitis |
increased susceptibility to induced arthritis |
decreased susceptibility to endotoxin shock |
abnormal response to infection |
decreased susceptibility to bacterial infection |
increased susceptibility to bacterial infection |
increased susceptibility to bacterial infection induced morbidity/mortality |
increased susceptibility to Herpesvirales infection induced morbidity/mortality |
increased susceptibility to Riboviria infection induced morbidity/mortality |
increased susceptibility to parasitic infection |
increased susceptibility to Herpesvirales infection |
increased susceptibility to Poxviridae infection |
increased susceptibility to Riboviria infection |
increased susceptibility to graft versus host disease |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1m1Btlr/Ifngr1m1Btlr | ||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1.1Rost/Ifngr1tm1.1Rost | * | |||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1.2Rds/Ifngr1tm1.2Rds | ||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1Agt/Ifngr1tm1Agt | * | |||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1.1Rds/Ifngr1tm1.1Rds Tg(Itgax-cre,-EGFP)4097Ach/0 (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1.1Rds/Ifngr1tm1.1Rds Commd10Tg(Vav1-icre)A2Kio/Commd10+ (conditional) |
||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1Dmer/Ifngr1tm1Dmer (conditional) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Ifngr1tm1Dmer/Ifngr1tm1Dmer Tg(Thy1-cre)1Vln/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|